This week, The Dr. Randi Show welcomes Mike Hennessy Jr., Chairman and CEO of MJH Life Sciences, for an inside look at the leadership, ambition, and innovation driving a healthcare media powerhouse.
With more than 65 brands, 2,000 events, 7 million monthly unique visitors, and 2 million print readers, MJH’s reach extends across medicine, science, wellness, and beauty. Its portfolio includes NewBeauty, Dermatology Times, Pharmacy Times, and OncLive, connecting medical advances with the physicians, patients, and consumers who need to understand them.
Mike shares his vision for a company that continues to reinvent itself while staying committed to improving patient care worldwide. The conversation explores the growing connection between healthcare and beauty, AI’s potential to transform business and medicine, and the responsibility that comes with being a trusted source of information for millions.
In this episode:
- The entrepreneurial vision behind MJH’s growth from medical publisher to healthcare media powerhouse
- The vision behind bringing NewBeauty into the MJH portfolio and connecting medicine, wellness, and beauty
- How AI is transforming operations and accelerating innovation within MJH
- The role of trusted medical media in helping physicians keep pace with new treatments
- Balancing rapid growth and innovation with the credibility audiences depend on
- The next chapter for MJH, including international expansion and a potential role in healthcare advocacy
Plus, a personal look at the leader behind MJH, from the family legacy that shaped his purpose to a speed round revealing how he thinks, leads, and makes decisions.
Sponsored by NewBeauty 💄
📱 Watch and Listen on Spotify: https://spti.fi/mike-hennessy-jr
🎧 Listen on Apple Podcasts: https://dub.sh/mike-hennessy-jr
Episode FAQ
How does healthcare media connect medicine, beauty, and patient education?
On The Dr. Randi Show, Mike Hennessy Jr., chairman and CEO of MJH Life Sciences, explains how healthcare media connects clinicians and consumers with information about medicine, beauty, and wellness. He describes the company’s evolution from medical publishing to healthcare engagement, with improving patient care worldwide remaining its central mission.
How can a family’s cancer experience shape a healthcare leader’s mission?
Mike Hennessy Jr. shares that his mother’s experience with ovarian cancer strengthened his personal commitment to improving access to care through MJH Life Sciences. He recalls how physician connections helped his family explore treatment options, including care outside the United States. He describes that experience as a motivation to help more patients access information and treatment opportunities.
How do busy doctors stay informed about advances in medicine?
Mike Hennessy Jr. explains that MJH Life Sciences delivers healthcare information through print publications, digital content, video, podcasts, and events. He describes the challenge of keeping up with new therapies while managing patient care and administrative work. His approach is to make updates available through the formats healthcare professionals already use.
How can beauty media help consumers and medical professionals become better informed?
Mike Hennessy Jr. says MJH Life Sciences acquired NewBeauty to connect consumer education with its existing healthcare professional audiences, including readers of Dermatology Times. He describes opportunities to bring consumers, dermatologists, nurse practitioners, physician assistants, and aesthetic physicians closer together through information. His vision includes expanding video, social content, and events while building on NewBeauty’s established print and digital presence.
How can AI help healthcare media teams work more efficiently?
Mike Hennessy Jr. describes an internal AI Accelerator at MJH Life Sciences that invited employees to explore AI and solve business challenges. He says three rounds of the program helped produce four new products, improve existing offerings, and speed up workflows. He presents AI as a way to support continued growth and help employees accomplish more.
What are the opportunities and limitations of using AI for health information?
Mike Hennessy Jr. of MJH Life Sciences welcomes patients taking an active interest in researching their health, while acknowledging that AI-generated information is not always reliable. He emphasizes respect for healthcare professionals’ training and experience. He also sees potential for AI to support clinical tools and more informed care, describing these applications as opportunities for future development.
What barriers can slow access to new treatments and clinical trials?
Mike Hennessy Jr. of MJH Life Sciences identifies funding and finding suitable clinical trial participants as important challenges in developing new therapies. He believes AI could help researchers identify relevant patient populations and accelerate trial enrollment. He presents these possibilities as his outlook on the industry, rather than guaranteed improvements in treatment access or outcomes.
How can healthcare media balance speed, accuracy, and audience trust?
Mike Hennessy Jr. says MJH Life Sciences should never sacrifice the quality of its information for speed. He explains that preparing for upcoming research presentations and identifying experts for commentary can help teams publish promptly. He describes maintaining the trust of healthcare professionals, patients, and consumers as a priority the company cannot compromise.
What could the future of healthcare education and advocacy look like?
Mike Hennessy Jr. says his immediate priority for MJH Life Sciences is reaching more people through its educational events and media platforms. Looking ahead, he describes healthcare advocacy, potentially including lobbying for better care, as an area the company might explore. He emphasizes keeping patients at the center of its work while expanding its contribution internationally.
